Bayer designates $1.5 billion for litigation over Yasmin and Yaz contraceptives

The company is facing 10,000 lawsuits claiming the birth control pills cause blood clots

It's always important to prepare for litigation, and Bayer AG is doing just that, battening its hatches and setting aside more than $1.5 billion to cover expenses related to the wave of lawsuits the company is facing over its Yasmin and Yaz oral contraceptives. The lawsuits have caused the company's earnings to drop, according to its annual report, released last week.

The suits began flooding in in 2009, when many women and their representatives claimed that the birth control pills caused blood clots that sometimes resulted in strokes, heart attacks or even death. In April 2012, the Food and Drug Administration ordered contraceptives including Yasmin and Yaz to strengthen their blood clot warnings.

Join the Conversation

Advertisement. Closing in 15 seconds.